Bacillus Calmette-Guérin Sensitises Fresh Transitional Carcinoma Cells and T24 Cell Line to Non-MHC-restricted Cytotoxicityin vitro
- 1 December 1993
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 72 (6) , 897-906
- https://doi.org/10.1111/j.1464-410x.1993.tb16293.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effects of bacillus calmette-guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancerCancer, 1992
- Bacillus Calmette-Guerin and Interleukin-2 for Treatment of Superficial Bladder CancerJournal of Urology, 1991
- Topical BCG for recurrent superficial bladder cancerThe Lancet, 1991
- This Month in Investigative Urology: The Production of Lymphokines Following BCG TherapyJournal of Urology, 1990
- Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin ImmunotherapyJournal of Urology, 1990
- Expression of Blood Group Precursor T Antigen as a Prognostic Marker for Human Bladder Cancer Treated by Bacillus Calmette-Guerin And Interleukin-2Journal of Urology, 1989
- Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary reportInternational Journal of Cancer, 1984
- Nonspecific Immunotherapy with BCG Vaccine in Bladder TumorsEuropean Urology, 1977
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973